Loading...

CureVac N.V.

5CV.F•XETRA
Healthcare
Biotechnology
€4.70
€-0.04(-0.84%)

CureVac N.V. (5CV.F) Stock Overview

Explore CureVac N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 77.1/100

Key Financials

Market Cap1B
P/E Ratio5.83
EPS (TTM)$0.80
ROE0.30%
Fundamental Analysis

AI Price Forecasts

1 Week$4.40
1 Month$2.68
3 Months$4.04
1 Year Target$1.40

5CV.F Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CureVac N.V. (5CV.F) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.40.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.83 and a market capitalization of 1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;